Low penetrance breast cancer predisposition SNPs are site specific

被引:46
|
作者
Mcinerney, Niall [2 ,3 ]
Colleran, Gabrielle [2 ,3 ]
Rowan, Andrew [3 ]
Walther, Axel [3 ]
Barclay, Ella [3 ]
Spain, Sarah [3 ]
Jones, Angela M. [3 ]
Tuohy, Stephen [2 ,3 ]
Curran, Catherine [2 ]
Miller, Nicola [2 ]
Kerin, Michael [2 ]
Tomlinson, Ian [3 ]
Sawyer, Elinor [1 ,3 ]
机构
[1] Guys Hosp, Guys Kings St Thomas Canc Ctr, Dept Acad Oncol, London SE1 9RT, England
[2] Univ Coll Hosp, Inst Clin Sci, Dept Surg, Galway, Ireland
[3] Canc Res UK, Mol & Populat Genet Lab, London WC2A 3PX, England
关键词
Breast cancer; Colorectal cancer; Prostate cancer; Genetic susceptibility; 8q24; West Ireland; GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; PROSTATE-CANCER; CONFER SUSCEPTIBILITY; GENETIC-VARIANTS; COMMON VARIANTS; MULTIPLE LOCI; RISK; 8Q24; SCAN;
D O I
10.1007/s10549-008-0235-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Large scale association studies have identified low penetrance susceptibility alleles that predispose to breast cancer. A locus on chromosome 8q24.21 has been shown to harbour variants that predispose to breast, ovarian, colorectal and prostate cancer. The finding of risk variants clustering at 8q24 suggests that there may be common susceptibility alleles that predispose to more than one epithelial cancer. The aim of this study was firstly to determine whether previously identified breast cancer susceptibility alleles are associated with sporadic breast cancer in the West of Ireland and secondly to ascertain whether there are susceptibility alleles that predispose to all three common epithelial cancers (breast, prostate, colon). We genotyped a panel of 24 SNPs that have recently been shown to predispose to prostate, colorectal or breast cancer in 988 sporadic breast cancer cases and 1,016 controls from the West of Ireland. We then combined our data with publicly available datasets using standard techniques of meta-analysis. The known breast cancer SNPs rs13281615, rs2981582 and rs3803662 were confirmed as associated with breast cancer risk (P (allelic test) = 1.8 x 10(-2), OR = 1.17; P (allelic test) = 2.2 x 10(-3), OR = 1.22; P (allelic test) = 5.1 x 10(-2), OR = 1.15, respectively) in the West of Ireland cohort. For the remaining five breast cancer SNPs that were studied there was no evidence of an association with breast cancer in the West Ireland population (P (allelic test) > 6.5 x 10(-2)). There was also no association between any of the prostate or colorectal susceptibility SNPs, whether at 8q24 or elsewhere, with breast cancer risk. Meta-analysis confirmed that all susceptibility SNPs were site specific, with the exception of rs6983269 which is known to predispose to both colorectal and prostate cancer. This study confirms that susceptibility loci at FGFR2, 8q24 and TNCR9 predispose to sporadic breast cancer in the West of Ireland. It also suggests that low penetrance susceptibility SNPs for breast, prostate and colorectal cancer are distinct. Although 8q24 harbours variants that predispose to all three cancers, the susceptibility loci within the region appear to be specific for the different cancer types with the exception of rs6983269 in colon and prostate cancer.
引用
收藏
页码:151 / 159
页数:9
相关论文
共 50 条
  • [1] Low penetrance breast cancer predisposition SNPs are site specific
    Mc Inerney, N. M.
    Colleran, G.
    Walther, A.
    Rowan, A.
    Spain, S.
    Jones, A. M.
    Tuohy, S.
    Barclay, E.
    Curran, C.
    Miller, N.
    Kerin, M. J.
    Tomlinson, I
    Eli, S.
    CANCER RESEARCH, 2009, 69 (02) : 372S - 373S
  • [2] Low penetrance breast cancer predisposition SNPs are site specific
    Niall Mcinerney
    Gabrielle Colleran
    Andrew Rowan
    Axel Walther
    Ella Barclay
    Sarah Spain
    Angela M. Jones
    Stephen Tuohy
    Catherine Curran
    Nicola Miller
    Michael Kerin
    Ian Tomlinson
    Elinor Sawyer
    Breast Cancer Research and Treatment, 2009, 117 : 151 - 159
  • [3] Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs
    Li, Na
    Rowley, Simone M.
    Thompson, Ella R.
    McInerny, Simone
    Devereux, Lisa
    Amarasinghe, Kaushalya C.
    Zethoven, Magnus
    Lupat, Richard
    Goode, David
    Li, Jason
    Trainer, Alison H.
    Gorringe, Kylie L.
    James, Paul A.
    Campbell, Ian G.
    BREAST CANCER RESEARCH, 2018, 20
  • [4] Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs
    Na Li
    Simone M. Rowley
    Ella R. Thompson
    Simone McInerny
    Lisa Devereux
    Kaushalya C. Amarasinghe
    Magnus Zethoven
    Richard Lupat
    David Goode
    Jason Li
    Alison H. Trainer
    Kylie L. Gorringe
    Paul A. James
    Ian G. Campbell
    Breast Cancer Research, 20
  • [5] Moderate-Penetrance Predisposition to Breast Cancer
    Robson M.
    Current Breast Cancer Reports, 2018, 10 (3) : 232 - 239
  • [6] Pilot study on low penetrance breast and colorectal cancer predisposition markers in Latvia
    Irmejs A.
    Miklasevics E.
    Boroschenko V.
    Gardovskis A.
    Vanags A.
    Melbarde-Gorkusa I.
    Bitina M.
    Suchy J.
    Gardovskis J.
    Hereditary Cancer in Clinical Practice, 4 (1) : 48 - 51
  • [7] Chromosomal radiosensitivity and low penetrance predisposition to cancer
    Scott, D
    CYTOGENETIC AND GENOME RESEARCH, 2004, 104 (1-4) : 365 - 370
  • [8] Heritability of cellular radiosensitivity: A marker of low-penetrance predisposition genes in breast cancer
    Roberts, SA
    Spreadborough, AR
    Bulman, B
    Barber, JBP
    Evans, DGR
    Scott, D
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (03) : 784 - 794
  • [9] Contribution of female breast cancer predisposition SNPs to risk of male breast cancer
    Orr, Nick
    Jones, Michael
    Maguire, Sarah
    Swerdlow, Anthony
    CANCER RESEARCH, 2018, 78 (13)
  • [10] Analysis of KLLN as a high-penetrance breast cancer predisposition gene
    Thompson, Ella R.
    Gorringe, Kylie L.
    Choong, David Y. H.
    Eccles, Diana M.
    Mitchell, Gillian
    Campbell, Ian G.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 543 - 547